Affiliation: University of California
- Digestive disease week 2000. American Association for the Study of Liver DiseasesP Rosenthal
University of California, 500 Parnassus Ave, Box 0136 Muy East, San Francisco, CA 94143 0136, USA
IDrugs 3:868-71. 2000..Ursodeoxycholic acid may also provide benefit for mothers with intrahepatic cholestasis of pregnancy by decreasing pruritus, lowering laboratory values and allowing deliveries to occur closer to term...
- Management of portal hypertension in childrenElizabeth Mileti
University of California, San Francisco, San Francisco, CA 94143 0136, USA
Curr Gastroenterol Rep 13:10-6. 2011..Transjugular intrahepatic portosystemic shunts and surgical shunts may be reserved for those who are not candidates for transplant or have refractory bleeding despite medical or endoscopic treatment...
- Hepatocarcinoma in viral and metabolic liver diseasePhilip Rosenthal
University of California, San Francisco, 94143 0136, USA
J Pediatr Gastroenterol Nutr 46:370-5. 2008....
- Assessing liver function and hyperbilirubinemia in the newborn. National Academy of Clinical BiochemistryP Rosenthal
University of California, San Francisco Medical Center, 94143 0136, USA
Clin Chem 43:228-34. 1997..These guidelines, like all sets of guidelines, are only recommendations and do not substitute for good clinical judgment based upon the individual circumstances of each patient...
- Cost-effectiveness of hepatitis A vaccination in children, adolescents, and adultsPhilip Rosenthal
Pediatric Liver Transplant Program, University of California, San Francisco, 94143, USA
Hepatology 37:44-51. 2003..This review of economic analyses of vaccine use in several developed countries shows cost-effectiveness comparable with that of other vaccines in children and within accepted boundaries for adolescents and high-risk adults...
- Is there a future for liver-assist devices?P Rosenthal
Pediatric Liver Transplant Program, Department of Pediatric Hepatology, University of California, San Francisco, 500 Parnassus Avenue, Box 0136, MU 4 East, San Francisco, CA 94143 0136, USA
Curr Gastroenterol Rep 2:55-60. 2000..It is hoped that randomized, controlled trials will answer important questions about the efficacy of these systems...
- Autoimmune hepatitis in children: diagnosis, pathology and treatmentWalter Eb Sipe
University of California, Division of Pediatric Gastroenterology, Hepatology and Nutrition, 500 Parnassus Avenue, Box 0136, San Francisco, CA 94143 0136, USA
Expert Rev Clin Immunol 3:159-69. 2007..This review will summarize the current clinical and pathophysiological understanding of AIH in children, along with therapeutic options...
- Immunotherapy for severe aplastic anemia following orthotopic liver transplantation in childrenRosa Sanchez
Department of Pediatrics, University of California, San Francisco, California 94143 0106, USA
Pediatr Blood Cancer 49:93-8. 2007....
- Trends over a decade of pediatric liver transplantation in the United StatesSandy Feng
Department of Surgery, University of California San Francisco, San Francisco, CA 94143 0780, USA
Liver Transpl 12:578-84. 2006..In conclusion, the sobering reality that mortality on the waiting list remains highest for the youngest pediatric liver candidates frames our challenge for the next decade...
- Oral disease burden and utilization of dental care patterns among pediatric solid organ transplant recipientsCaroline H Shiboski
Department of Orofacial Sciences, School of Dentistry, University of California San Francisco UCSF, Box 0422, Room S612, 513 Parnassus Avenue, San Francisco, CA 94143 0422, USA
J Public Health Dent 69:48-55. 2009....
- The comprehensive assessment of physical fitness in children following kidney and liver transplantationJoanne B Krasnoff
University of California San Francisco, Department of Physiological Nursing, 94143, USA
Transplantation 82:211-7. 2006..Low cardiorespiratory fitness (CRF) may contribute to CV risk; however, studies of CRF in children following kidney transplantation (KTx) and liver transplantation (LTx) are limited...
- Pediatric liver retransplantation: outcomes and a prognostic scoring toolAdam Davis
Department of Pediatrics, University of California at San Francisco, San Francisco, CA 94143, USA
Liver Transpl 15:199-207. 2009..In conclusion, with simple clinical characteristics, this scoring tool can modestly discriminate between those children at high risk and those children at low risk of poor outcome after liver retransplantation...
- Pseudo gallbladder sign in biliary atresia--an imaging pitfallSeerat Aziz
Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA 94143 0628, USA
Pediatr Radiol 41:620-6; quiz 681-2. 2011..Ultrasound (US) is used to identify causes of neonatal cholestasis. We describe a potential sonographic pitfall, the "pseudo gallbladder," in biliary atresia (BA)...
- Nontransplant surgical interventions in progressive familial intrahepatic cholestasisAdam Rahn Davis
Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of California, San Francisco, CA 94143, USA
J Pediatr Surg 44:821-7. 2009..In the last 20 years, the use of nontransplant surgery to treat PFIC has become the standard of care. There are various surgical techniques that have been performed. There are no reviews evaluating the outcome of these operations...
- Gingival enlargement in pediatric organ transplant recipients in relation to tacrolimus-based immunosuppressive regimensCaroline H Shiboski
Department of Orofacial Sciences, School of Dentistry, University of California San Francisco, San Francisco, USA
Pediatr Dent 31:38-46. 2009....
- Fitness testing of pediatric liver transplant recipientsV B Unnithan
Exercise and Sport Science, University of San Francisco, 1230 Fulton St, San Francisco, CA 94117 1080, USA
Liver Transpl 7:206-12. 2001..These results indicate that the LT group has diminished exercise capacity. The origins of exercise limitations deserve further investigation...
- Allograft rejection in pediatric liver transplantation: Comparison between cadaveric and living related donorsYoshikazu Toyoki
Department of Surgery, Division of Transplantation, University of California, San Francisco, California 94143, USA
Pediatr Transplant 6:301-7. 2002..LRLT have a partial immunological advantage compared with CLT...
- Decreased risk of graft failure with maternal liver transplantation in patients with biliary atresiaA Nijagal
Department of Surgery, University of California, San Francisco, CA, USA
Am J Transplant 12:409-19. 2012..Our data support the concept that maternal cells in BA recipients promote tolerance to NIMAs and may be important in counseling BA patients who require liver transplantation...
- Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmatesR Jake Jacobs
Capitol Outcomes Research Inc, 6188 Old Franconia Road, Alexandria, VA 22310, USA University of California at San Francisco, San Francisco, CA, USA
Vaccine 22:1241-8. 2004..In the three regions considered, cost effectiveness would be US$ <0, 2131, and 22,819 per life-year saved, respectively. Prison-based hepatitis A/B immunization would meet accepted standards of cost effectiveness throughout the US...
- The influence of portoenterostomy on transplantation for biliary atresiaBrendan C Visser
The University of California, San Francisco, CA, USA
Liver Transpl 10:1279-86. 2004..The 1-, 5-, and 10-year actuarial patient survival rates were 91%, 89%, and 83%. PE remains an important bridge to transplant. In conclusion, transplantation for BA offers excellent long-term graft and patient survival...
- Under Utilization of Pancreas Transplants in Cystic Fibrosis Recipients in the United Network Organ Sharing (UNOS) Data 1987-2014D J Usatin
Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition, University of California, San Francisco, San Francisco, CA
Am J Transplant 16:1620-5. 2016..Further consideration of pancreas transplant in CF patients undergoing other solid organ transplant may be warranted. ..
- Metabolic Syndrome Components After Pediatric Liver Transplantation: Prevalence and the Impact of Obesity and ImmunosuppressionE R Perito
Department of Pediatrics, UCSF Benioff Children s Hospital, University of California, San Francisco, San Francisco, CA
Am J Transplant 16:1909-16. 2016..Pediatric LT recipients have unique metabolic syndrome profiles and risk factors and will require tailored screening and management protocols. ..
- Posttransplant metabolic syndrome in the withdrawal of immunosuppression in Pediatric Liver Transplant Recipients (WISP-R) pilot trialE R Perito
Department of Pediatrics, UCSF Benioff Children s Hospital, University of California, San Francisco, CA
Am J Transplant 15:779-85. 2015..Compared to controls, WISP-R tolerant subjects had similar GFR at baseline but did have higher GFR at 2, 3 and 4 years. Further study of PTMS and immunosuppression withdrawal after pediatric liver transplant is warranted. ..
- Posttransplantation growth in pediatric liver recipientsJ F Renz
Department of Surgery, University of California, San Francisco, USA
Liver Transpl 7:1040-55. 2001..We conclude that early transplantation of children who show growth retardation is optimal for restoration of growth potential, whereas delaying transplantation in older children impedes potential growth...
- Comparison of drainage techniques for biliary atresiaKuoJen Tsao
Fetal Treatment Center, Department of Surgery, Division of Pediatric Surgery, San Francisco, CA 94143 0570, USA
J Pediatr Surg 38:1005-7. 2003..Differences in outcome between patients who underwent either Kasai portoenterostomy or porto-appendiceal duodenostomy were compared...
- Propylthiouracil-associated liver failure presenting as probable autoimmune hepatitis in a child with Graves' diseaseWalter E B Sipe
Department of Pediatrics, UCSF, San Francisco, CA, USA
Pediatr Transplant 10:525-8. 2006..PTU is an important cause of drug-related liver failure in children, and clinicians should be mindful that it is frequently used in patients who already have an underlying risk of autoimmune liver disease...
- Differences in presentation and progression between severe FIC1 and BSEP deficienciesLudmila Pawlikowska
Department of Anesthesia and Perioperative Care, University of California, San Francisco, San Francisco, CA, USA
J Hepatol 53:170-8. 2010..Our goal was to identify features that distinguish presentation and course of these two disorders, thus facilitating diagnosis and elucidating the differing consequences of ATP8B1 and ABCB11 mutations...
- Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitisHeather M Patton
Division of Gastroenterology, University of California, San Diego, San Diego, California 92103, USA
Gastroenterology 135:1961-1971.e2. 2008..Noninvasive means to discriminate between NAFLD and nonalcoholic steatohepatitis (NASH) might diminish the requirement for liver biopsy or predict those at increased risk for progression...
- Symptoms and quality of life in obese children and adolescents with non-alcoholic fatty liver diseaseK D Kistler
Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of California, San Diego, La Jolla, CA 92103, USA
Aliment Pharmacol Ther 31:396-406. 2010..Data on the quality of life (QOL) of children with non-alcoholic fatty liver disease (NAFLD) are needed to estimate the true burden of illness in children with NAFLD...
- Caring for adults with pediatric liver diseaseMichelle Rook
Pediatric Gastroenterology, Hepatology and Nutrition, University of California San Francisco, 500 Parnassus Avenue, MU4E, Box 0136, San Francisco, CA 94143, USA
Curr Gastroenterol Rep 11:83-9. 2009..This review addresses some of the most common childhood liver diseases, their causes, presentation, evaluation, management, complications, and additional concerns...
- Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver diseaseHeather M Patton
Departments of Medicine and Pediatrics, University of California, San Diego, San Diego, California, USA
Am J Gastroenterol 105:2093-102. 2010..We sought to determine whether MetS or its component features are associated with specific histological features or severity of NAFLD...
- Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research networkKristin David
Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of California, San Diego, La Jolla, CA 92103, USA
Hepatology 49:1904-12. 2009..6), or bridging fibrosis (44.6). Cirrhosis was associated with poorer physical health after adjusting for potential confounders. Mental health scores did not differ between participants with and without NASH or by degree of fibrosis...
- Research agenda for pediatric gastroenterology, hepatology and nutrition: transplantation. Report of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition for the Children's Digestive Health and Nutrition FoundationSuzanne V McDiarmid
Children s Digestive Health and Nutrition Foundation, PO Box 6, Flourtown, PA 19031, USA
J Pediatr Gastroenterol Nutr 35:S275-80. 2002
- Hepatitis A vaccinePhilip Rosenthal
N Engl J Med 350:2211-2; author reply 2211-2. 2004
- The seroprevalence of Helicobacter pylori in a referral population of children in the United StatesSonny K F Chong
Riley Hospital for Children, Indianapolis, Indiana, USA
Am J Gastroenterol 98:2162-8. 2003..The purpose of this study was to determine the prevalence of serum antibodies directed against Helicobacter pylori (H. pylori) in children referred to children's hospitals or medical centers throughout the United States...
- Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study groupRobert H Squires
University of Pittsburgh, Children s Hospital of Pittsburgh, PA 15213, USA
J Pediatr 148:652-658. 2006..To determine short-term outcome for children with acute liver failure (ALF) as it relates to cause, clinical status, and patient demographics and to determine prognostic factors...
- CT and MRI of hepatic pseudotumor in long-standing biliary atresiaZhen J Wang
Department of Radiology, University of California at San Francisco, 94143 0628, USA
J Comput Assist Tomogr 26:444-7. 2002..The CT, MR, and pathologic appearances are described. Accurate radiologic identification of this entity is important for appropriate clinical management...
- Growth failure and outcomes in infants with biliary atresia: a report from the Biliary Atresia Research ConsortiumPatricia A DeRusso
Johns Hopkins School of Medicine and The Johns Hopkins Children s Center, Baltimore, Maryland, USA
Hepatology 46:1632-8. 2007..The combination of intermediate bilirubin concentrations and poor mean weight z-scores 3 months after HPE was also associated with poor clinical outcome...
- Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporineSteven J Lobritto
Center for Liver Disease and Transplantation, Columbia University, New York, NY 10032, USA
Liver Transpl 13:1570-5. 2007..This finding should be confirmed by a prospective trial...
- Hepatitis A: a preventable threatPhilip Rosenthal
J Pediatr Gastroenterol Nutr 35:595-6. 2002
- A mathematical model of hepatitis a transmission in the United States indicates value of universal childhood immunizationThierry P Van Effelterre
GlaxoSmithKline Biologicals, Rixensart, B 1330, Belgium
Clin Infect Dis 43:158-64. 2006..Mathematical models of HA transmission, especially those accounting for herd protection, can be useful in formulating new, highly effective recommendations that could lead to disease elimination...
- Mushroom poisoning and auxiliary partial orthotopic liver transplantationPhilip Rosenthal
Am J Gastroenterol 97:1272-3. 2002
- Donor health assessment after living-donor liver transplantationGeraldine C Diaz
Philadelphia College of Osteopathic Medicine, Philadelphia, Pennsylvania, USA
Ann Surg 236:120-6. 2002..To elicit donor opinions on liver living donation through use of a survey that protected the anonymity of the respondent and to assay long-term (follow-up > 1 year) donor health by a widely recognized instrument for health assessment...
- Hepatic failure and liver transplant: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and NutritionAlastair Baker
J Pediatr Gastroenterol Nutr 39:S632-9. 2004